Lupus nephropathy in New Zealand F1 hybrid mice treated by (-)15-deoxyspergualin
- 1 October 1988
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 34 (4), 467-473
- https://doi.org/10.1038/ki.1988.204
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- EFFECT OF A NEW IMMUNOSUPPRESSANT, 15-DEOXYSPERGUALIN, ON HETEROTOPIC RAT HEART TRANSPLANTATION, IN COMPARISON WITH CYCLOSPORINETransplantation, 1987
- Prevention of lupus diseases in MRLI, NZBxNZW, and BXSB mice treated with a cyclophosphazene derived drugClinical Immunology and Immunopathology, 1986
- Study of the Biological Activities of Toxic Shock Syndrome Toxin‐1Microbiology and Immunology, 1986
- Therapy of Lupus NephritisNew England Journal of Medicine, 1986
- Effect of mizoribine on lupus nephropathy of New Zealand black/white F1 hybrid miceClinical Immunology and Immunopathology, 1984
- Synthesis of (-)-15-deoxyspergualin and (-)-spergualin-15-phosphate.The Journal of Antibiotics, 1982
- The total synthesis of spergualin, an antitumor antibiotic.The Journal of Antibiotics, 1981
- Structure of an antitumor antibiotic, spergualin.The Journal of Antibiotics, 1981
- A new antitumor antibiotic, spergualin: Isolation and antitumor activity.The Journal of Antibiotics, 1981
- CYCLOSPORIN A IN PATIENTS RECEIVING RENAL ALLOGRAFTS FROM CADAVER DONORSThe Lancet, 1978